From Solid Dispersions to Enzyme-Responsive Nanocarriers: Whey Protein Isolate Nanoparticles for Enhanced Curcumin Encapsulation and Targeted Delivery
Pharmaceutics · 30.04.2026 · 18 (5) · 556
DOI: 10.3390/pharmaceutics18050556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 30.04.2026. Verfasst von Marwa Megahed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health, Education and Society, Knowledge Exchange and Research Institute (HES KERI) and School of Life Sciences, Pharmacy and Chemistry, Kingston Uni…. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Curcumin (CUR) is a potent anticancer agent whose clinical application is hindered by its extremely poor aqueous solubility. This study reports the development of enzyme-responsive whey protein isolate (WPI) nanoparticles for CUR targeted delivery.
Methods
To overcome the initial solubility barrier, CUR was first formulated as a solid dispersion with WPI using freeze-drying. This process resulted in a significant enhancement in aqueous solubility (up to 1478-fold), with CUR existing in molecular dispersion or in an amorphous state within the protein matrix as confirmed by Differential Scanning Calorimetry (DSC) and Fourier-transform infrared (FT-IR) spectroscopy. The solubilized CUR-WPI solid dispersion was subsequently used to generate nanoparticles via a thermal gelation method, avoiding the use of organic solvents or toxic chemical crosslinkers.
Results
The resulting nanoparticles exhibited a high drug loading efficiency of 85%. In vitro release studies demonstrated minimal CUR release in physiological buffer (pH 7.4) over 24 h, whereas exposure to trypsin, a nonspecific serine protease used as an in vitro model for tumor-associated proteolytic activity, triggered rapid nanoparticle degradation and released 95% of CUR within 3 h.
Conclusions
These findings suggest that WPI-based nanoparticles developed from solid dispersions offer a promising, biocompatible platform for the solubility enhancement and protease-triggered delivery of hydrophobic anticancer drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health, Education and Society, Knowledge Exchange and Research Institute (HES KERI) and School of Life Sciences, Pharmacy and Chemistry, Kingston University, Penrhyn Road, Kingston upon Thames, Surrey KT1 2EE, UK.
- Codis UK, 12 Rookwood Way, Haverhill, Suffolk CB9 8PB, UK.
- Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford CM1 1SQ, UK.
ORCID-Profile: Mohammad Najlah, Hachemi Kadri, Mouhamad Khoder
Zitieren
APA
Megahed, M., Patel, J., Najlah, M., Kadri, H., & Khoder, M. (2026). From Solid Dispersions to Enzyme-Responsive Nanocarriers: Whey Protein Isolate Nanoparticles for Enhanced Curcumin Encapsulation and Targeted Delivery. Pharmaceutics, 18(5), 556. https://doi.org/10.3390/pharmaceutics18050556
Vancouver
Megahed M, Patel J, Najlah M, Kadri H, Khoder M. From Solid Dispersions to Enzyme-Responsive Nanocarriers: Whey Protein Isolate Nanoparticles for Enhanced Curcumin Encapsulation and Targeted Delivery. Pharmaceutics. 2026;18(5):556. doi:10.3390/pharmaceutics18050556
BibTeX
@article{Megahed2026,
author = {Megahed, Marwa and Patel, Jaina and Najlah, Mohammad and Kadri, Hachemi and Khoder, Mouhamad},
title = {From Solid Dispersions to Enzyme-Responsive Nanocarriers: Whey Protein Isolate Nanoparticles for Enhanced Curcumin Encapsulation and Targeted Delivery},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {5},
pages = {556},
doi = {10.3390/pharmaceutics18050556}
}
EUVIMED